Journal of Nephrology & Therapeutics

Tan KS

Publications

• Case Report
  Inadvertent Use of Metformin in a Peritoneal Dialysis Patient: Case Report and Literature Review
  Author(s): Abishek Tumma and Tan KSAbishek Tumma and Tan KS
  
  Background: Metformin has been a main stay medication in the treatment of type 2 diabetes mellitus. However, its use has been limited by its potential risk of metabolic acidosis in chronic kidney disease. Although this been anecdotally proposed, there have been no studies suggesting the effects of metformin in end stage renal failure, especially in the setting of peritoneal dialysis. We submit a case of metformin inadvertently used in end stage renal failure, without evidence of metabolic acidosis. Case presentation: A 54 year old man with known type 2 diabetes mellitus presented late to our service with end stage renal failure. He had been on metformin at time of diagnosis of end stage renal failure. Although initially ceased on admission, metformin was inadvertently restarted on discharge from another hospital where he had been transferred f.. Read More»
  DOI: 10.4172/2161-0959.1000204

  Abstract PDF